Evidence map›Paper›PMID 31826640›Full record

ArticleAIDS care2021

Tracing-corrected estimates of disengagement from HIV care and mortality among patients enrolling in HIV care without overt immunosuppression in Tanzania.

Olga Tymejczyk, Quynh Vo, Sarah Gorrell Kulkarni, Gretchen Antelman, Judith Boshe, William Reidy, Angela Parcesepe, Denis Nash, Batya Elul

Abstract read
In one paragraph

Article in AIDS care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olga TymejczykInstitute for Implementation Science in Population Health, City University of New York, New York, NY, USA.ORCID 0000-0002-8417-0650
Quynh VoICAP, Columbia University, New York, NY, USA.
Sarah Gorrell KulkarniInstitute for Implementation Science in Population Health, City University of New York, New York, NY, USA.
Gretchen AntelmanICAP, Dar es Salaam, Tanzania.
Judith BosheICAP, Dar es Salaam, Tanzania.
William ReidyICAP, Columbia University, New York, NY, USA.
Angela ParcesepeGillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Denis NashInstitute for Implementation Science in Population Health, City University of New York, New York, NY, USA.
Batya ElulICAP, Columbia University, New York, NY, USA.

Funding

INSPIRE : Interdisciplinary Social and Behavioral Science Prevention and Intervention REsearch in HIVT32MH019139 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Claude Ann Mellins, Jae M. Sevelius · 1989 to 2026
$10.8M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Multi-level determinants of late ART initiation in sub-Saharan AfricaR01MH089831 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ELUL, BATYA ORIT · 2010 to 2014
$3.6M
NICHD NIH HHS P2C HD050924NIMH NIH HHS R01 MH089831NIMH NIH HHS T32 MH019139
6 · The paper itself

Abstract

In the era of "test and treat", it is important to understand HIV care outcomes and their determinants in patients presenting to care with early-stage disease. We surveyed 924 adults newly enrolling in HIV care at four clinics in Tanzania before the adoption of universal treatment eligibility, and collected longitudinal clinical data. Participants who defaulted from care were tracked in the community. Cumulative incidence of disengagement from care and death was estimated using competing risk methods. By 12 months after enrollment, 18.2% of patients had disengaged from care and 6.9% had died. Factors associated with disengagement included male sex (adjusted subhazard ratio [aSHR] versus female = 1.75, 95% confidence interval [CI]: 1.06-2.89), provider-initiated HIV diagnosis (aSHR versus self-referred = 1.71, 95% CI: 1.03-2.86), ineligibility for antiretroviral treatment (ART) at enrollment (aSHR versus eligibility = 2.82, 95% CI: 1.84-4.32) and increased anticipated stigma score (aSHR = 1.04 per 5-point increase, 95% CI: 1.02-1.05). Higher life satisfaction score (aSHR = 0.97 per 5-point increase, 95% CI: 0.95-0.99) and having 1-2 close friends (aSHR versus none = 0.58, 95% CI: 0.47-0.71) were protective. The findings highlight the continued importance of social environment for HIV care outcomes and the potential of universal ART eligibility to reduce HIV care attrition.

Indexed as

Continuity of Patient CareRetention in CareAdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveChildFemaleHIV InfectionsHumansImmunosuppression TherapyKaplan-Meier EstimateLost to Follow-UpMaleQuality of LifeSocial EnvironmentSocial StigmaAnti-HIV AgentsHIV/AIDSRetentionsub-Saharan Africatracing study

Identifiers

PMID31826640
PMCPMC7286784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.